Disruption of Glioblastoma Multiforme Cell Circuits with Cinnamaldehyde Highlights Potential Targets with Implications for Novel Therapeutic Strategies.

Author: BryantCrystal, HaynesCasey, KimYoo Na, NakhaiShadi A, PaiS Balakrishna, PatilKetki, SrivastavaShraddha, ThompsonElizabeth W

Paper Details 
Original Abstract of the Article :
Glioblastoma multiforme (GBM) is a major aggressive primary brain tumor with dismal survival outcome and few therapeutic options. Although Temozolomide (TMZ) is a part of the standard therapy, over time, it can cause DNA damage leading to deleterious effects, necessitating the discovery of drugs wit...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177046/

データ提供:米国国立医学図書館(NLM)

Disrupting Glioblastoma Multiforme Cell Circuits with Cinnamaldehyde

Glioblastoma multiforme (GBM) is a highly aggressive brain tumor with limited treatment options. This study investigated the potential of cinnamaldehyde (CA), a natural compound found in cinnamon, as a therapeutic agent for GBM. The researchers examined the effects of CA and its isomers/analogs on GBM cell lines U87 and U251, and the neuroglioma cell line H4.

Cinnamaldehyde: A Promising Anticancer Agent for Glioblastoma

The study found that CA and its isomers exhibited similar potency in inhibiting the viability of all three cell lines. CA treatment resulted in increased reactive oxygen species (ROS), apoptosis, and multicaspase cell populations. Furthermore, protein profiling revealed that CA downregulates key entities involved in glioblastoma cell circuits, such as pyruvate kinase-PKM2 and phosphomevalonate kinase.

Potential for Novel Therapeutic Strategies

These findings suggest that cinnamaldehyde could be a promising anticancer agent for glioblastoma. The researchers highlight the potential for CA to disrupt key metabolic pathways that are essential for GBM cell survival. They believe that this research opens up new avenues for developing novel therapeutic strategies for glioblastoma.

Dr. Camel's Conclusion

This study is like a desert explorer discovering a hidden oasis, offering a new source of hope for combating glioblastoma. The researchers have uncovered the potential of cinnamaldehyde as a therapeutic agent, providing a promising new direction for glioblastoma treatment.

Date :
  1. Date Completed 2023-05-15
  2. Date Revised 2023-05-15
Further Info :

Pubmed ID

37174677

DOI: Digital Object Identifier

PMC10177046

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.